Managing weight gain during pregnancy with a new digital intervention
Official title: Efficacy of a Novel Digital Platform to Scale-Up a Personalized Prenatal Weight Gain Intervention Using Control Systems Methodology
Run by Penn State University · NCT05807594 · Data updated 2026-11-12
This study is testing a new digital program to help pregnant women who are overweight or obese manage their weight gain during pregnancy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 144 (estimated) |
| Sponsor | Penn State University Academic / other |
| Locations | 1 site (University Park, Pennsylvania) |
| Status | Recruiting |
| Started | November 27, 2023 |
| Main results expected | January 31, 2028 |
| Study ends | January 31, 2028 |
| Registry record updated | January 16, 2026 |
| Trial ID | NCT05807594 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women aged 18-45 years with a BMI between 24.0 and 45.0, who are between 8 and 18 weeks gestation.
✕Probably not a fit
Patients who are not overweight or obese, or those with contraindications to physical activity, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of the Healthy Mom Zone 2.0 intervention, which utilizes a new digital platform to help pregnant women with overweight or obesity manage their gestational weight gain. The study will involve 144 participants who will be randomized into either the intervention group or a control group, with assessments conducted both in-person and remotely. Participants will track their weight, physical activity, and complete online surveys to provide data on their behaviors and outcomes. The study seeks to determine the intervention's impact on weight management, maternal-infant health, and the feasibility of implementing this approach in various healthcare settings.
Why it matters
Potential benefit: If successful, this intervention could help pregnant women manage their weight more effectively, leading to improved health outcomes for both mothers and infants.
How similar studies have gone: Previous studies have shown promise in managing gestational weight gain through digital interventions, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women * ≥ 8 and \< 18 weeks gestation at time of screening. This range of gestational age is chosen to: a) reduce chances of false pregnancy or miscarriage under 8 weeks gestation and b) recruit women in the 1st trimester for greatest impact of the intervention on gestational weight gain. In the feasibility and initial impact study, the investigators had less than 10% (n=3) miscarriages prior to randomization using these criteria * Singleton gestation * Not currently heavily smoking (\>20 cigarettes/day) * Any parity (i.e., first-time pregnancy, second pregnancy, etc.) * Any race/ethnicity * Ages 18-45 years * Body mass index (BMI) range 20.0 to 45.0. If BMI is over 40, consultation with woman's health care provider will be made to determine eligibility and ensure she does not have any contraindications to physical activity or other concerns with intervention participation. * Haven't exceeded 25% or more of their total GWG (based on BMI and IOM guidelines) from pre-pregnancy to date of enrollment. * Participant has physician consent to confirm subject participation * Able to read, understand, and speak English * Access to a computer/phone * Willingness and ability to complete study materials and intervention sessions electronically (e.g., email, Facetime, Zoom), at home (e.g., Zoom sessions delivered synchronous and asynchronous) or if requested by the participant, on-site at Penn State University Park or Hershey campuses. * No current use of weight loss medications * No current participation in another interventional study or program that influences weight control * No planned bariatric surgery during this current pregnancy * No absolute contraindications to exercise in pregnancy and relative contraindications with provider consent (see below) Exclusion Criteria: * Not pregnant women * Men (unable to become pregnant) * Multiple gestation * \< 8 weeks gestation or \> 18 weeks gestation at time of pre-intervention assessment * Currently smoking \> 20 cigarettes/day * Outside of the age range of 18-45 years * Outside of the BMI range of 20.0-45.0 * Exceeded 25% of their total GWG (based on BMI and IOM guidelines) from pre-pregnancy to date of enrollment * Not able to read and/or understand English * Unable to access materials by computer or phone (even with data plan assistance if necessary) * Current use of weight loss medications * Current participation in another interventional study or program that influences weight control * Planned bariatric surgery during this current pregnancy * Contraindications to aerobic exercise in pregnancy: Absolute contraindications to exercise: * Hemodynamically significant heart disease * Restrictive lung disease (pulmonary fibrosis, sarcoidosis, pleural effusion, neuromuscular disease). This DOES NOT include ASTHMA * Incompetent cervix/cerclage * Severe anemia * Multiple gestation at risk for premature labor * Persistent 2nd or 3rd trimester bleeding * Placenta previa after 26 weeks gestation * Premature labor during the current pregnancy * Ruptured membranes * Poorly controlled chronic hypertension * Preeclampsia diagnosis during current pregnancy * Poorly controlled Type 1 diabetes Relative contraindications to exercise (if permission is not given by provider): * Unevaluated maternal cardiac arrhythmia * Chronic bronchitis * Extreme morbid obesity (BMI \> 40.0; needs provider consent to participate) * Extreme underweight (BMI \< 12.0) * History of extremely sedentary lifestyle * Current eating disorder(s) diagnosis * Severe food allergies and/or dietary restrictions that may preclude study participation. * Intrauterine growth restriction in current pregnancy * Poorly controlled respiratory disorder (severe asthma) that precludes study participation * Orthopedic limitations * Poorly controlled seizure disorder * Poorly controlled thyroid disease * Uncontrolled sleep disorder (insomnia, sleep-disordered breathing)
Where it's running
-
Pennsylvania State University
University Park, Pennsylvania, United States Recruiting
Study contacts
- Study coordinator: Abigail Pauley, PhD
- Email: amp34@psu.edu
- Phone: 814-865-0840
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of different exercise modes during pregnancy on childhood obesity
This study is testing how different types of exercise during pregnancy can affect the health of overweight and obese moms and their babies to see which workouts are best for preventing childhood obesity.
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy
This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.
-
Effective Communication in VBAC Counseling
This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
Compare spinal-epidural versus general anesthesia for babies after cesarean delivery
This trial tests whether the type of anesthesia used for cesarean delivery affects newborn hearing in babies.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.